课题基金 / 基金详情

Human blood stem cell expansion: Empowering new technology for stem cell medicine

Human blood stem cell expansion: Empowering new technology for stem cell medicine
人类血液干细胞扩增:为干细胞医学提供新技术
批准号:
MR/V005502/1
负责人:
David Kent
金额:
$80.9万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

David Kent的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Blood stem cells are the fundamental component of regenerative medicine applications involving the blood and immune system, including bone marrow transplantation and gene therapy applications. Despite significant efforts and investment, researchers have largely failed to maintain fully functional blood stem cells for substantial periods of time outside the body. As a result, the limiting factor for cell and gene therapies is often obtaining a sufficient number of blood stem cells to seed the production of mature cells in vitro (e.g., red blood cells, platelets) or to lead to successful longterm bone marrow transplantation (e.g., gene therapy).Our recent advances in mouse blood stem cell expansion put us on the cusp of breaking through a decades-old barrier and this novel cell expansion system urgently requires characterisation and translation to human HSCs. Our proposal brings together leading UK and Japanese researchers in the molecular and functional characterisation of mouse and human blood stem cells in order to leverage their complementary expertise to translate this technology to the human system and explore potential clinical applications.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1101/2021.06.18.448972
发表时间: 2021-06
期刊: bioRxiv
影响因子: --
作者: [J. Che;D. Bode;I. Kucinski;A. Cull;Fiona Bain;Melania Barile;Grace Boyd;M. Belmonte;M. Jassinskaj]
通讯作者: J. Che;D. Bode;I. Kucinski;A. Cull;Fiona Bain;Melania Barile;Grace Boyd;M. Belmonte;M. Jassinskaj
DOI: 10.1182/blood.2022017864
发表时间: 2023-08-10
期刊: BLOOD
影响因子: 20.3
作者: [Jassinskaja, Maria, Gonka, Monika, Kent, David G.]
通讯作者: Kent, David G.
Hematopoietic stem cells depend on HIM and HER.
造血干细胞依赖于 HIM 和 HER。
DOI: 10.1016/j.exphem.2022.10.004
发表时间: 2022
期刊: Experimental hematology
影响因子: 2.6
作者: [Kent DG]
通讯作者: Kent DG
DOI: 10.3389/fimmu.2021.702636
发表时间: 2021
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Bode D, Cull AH, Rubio-Lara JA, Kent DG]
通讯作者: Kent DG
8
    Novel tools for modelling normal and perturbed haematopoiesis
    • 批准号:
      MC_PC_21043
    • 项目类别:
      Research Grant
    • 资助金额:
      $328.67万
    • 财政年份:
      2022
    • 负责人:
      David Kent
    • 依托单位:
    国内基金
    海外基金
    基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
    • 批准号:
      82371144
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      汪雪玲
    • 依托单位:
    内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
    • 批准号:
      82371317
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      万杰清
    • 依托单位:
    KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
    • 批准号:
      82371465
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李龙宣
    • 依托单位:
    骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
    • 批准号:
      82370820
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      王天歌
    • 依托单位: